Clinical Trials Browser

Phase 1/2 × Has results × umbralisib × Clear all

NCT04692155 2023-09-28

CHOP U2

Phase 1/2 Terminated

1 enrolled 5 charts

Lymphoma, Mantle-Cell

NCT02867618 2021-07-16

Carfilzomib and TGR-1202 in Treatment of R/R Lymphoma

Phase 1/2 Terminated

14 enrolled 9 charts

Hodgkin Disease, Lymphoma, Non-Hodgkin